Efficacy News and Research

RSS
New therapies boost obesity drug market

New therapies boost obesity drug market

Albumin for cancer treatment

Albumin for cancer treatment

Precise T cell correlates of protection need to be identified for vaccine design

Precise T cell correlates of protection need to be identified for vaccine design

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

Pros and cons of HIV treatments in developing countries

Pros and cons of HIV treatments in developing countries

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

Phase III EXTEND trial results of pixantrone announced

Phase III EXTEND trial results of pixantrone announced

HemoRANK-TKI in vitro assay service package from ReachBio

HemoRANK-TKI in vitro assay service package from ReachBio

Novartis presents Phase II results of the QVA149 bronchodilator for the treatment of COPD

Novartis presents Phase II results of the QVA149 bronchodilator for the treatment of COPD

NIMH awards Genomas an SBIR Grant to develop MRI DNA biomarkers for neuropsychiatric disease

NIMH awards Genomas an SBIR Grant to develop MRI DNA biomarkers for neuropsychiatric disease

NIAID awards Sanaria an SBIR Grant for expediting its malaria vaccine manufacturing process

NIAID awards Sanaria an SBIR Grant for expediting its malaria vaccine manufacturing process

FDA grants orphan drug status to Advanced Life Sciences' Restanza

FDA grants orphan drug status to Advanced Life Sciences' Restanza

BCLI collaborates with HBI to complete pre-clinical safety experiments

BCLI collaborates with HBI to complete pre-clinical safety experiments

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Implantable defibrillator therapy not beneficial for women with heart failure

Implantable defibrillator therapy not beneficial for women with heart failure

Extension study data on Fampridine-SR drug

Extension study data on Fampridine-SR drug

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.